{"title":"A Cross Sectional Study of Coagulation Profile in Type 2 Diabetes Mellitus Patients in Correlation with HbA1c","authors":"Dr T. Arun Kumar","doi":"10.18535/jmscr/v11i9.07","DOIUrl":null,"url":null,"abstract":"Introduction: Diabetes mellitus is a prevalent global health concern associated with increased cardiovascular risk. Hypercoagulability is a prominent feature in diabetic patients, contributing to thrombotic complications. This study explores the coagulation profile in Type 2 diabetes mellitus (T2DM) patients, focusing on the correlation with glycated hemoglobin (HbA1c). Aim: The study aims to assess coagulation impairment in T2DM through routine prothrombin time (PT) and activated partial thromboplastin time (APTT) measurements, thereby preventing thromboembolic cardiovascular disease (CVD). It further examines the relationship between coagulation parameters, HbA1c, and diabetes duration.","PeriodicalId":16362,"journal":{"name":"Journal of Medical Science And clinical Research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Science And clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18535/jmscr/v11i9.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Diabetes mellitus is a prevalent global health concern associated with increased cardiovascular risk. Hypercoagulability is a prominent feature in diabetic patients, contributing to thrombotic complications. This study explores the coagulation profile in Type 2 diabetes mellitus (T2DM) patients, focusing on the correlation with glycated hemoglobin (HbA1c). Aim: The study aims to assess coagulation impairment in T2DM through routine prothrombin time (PT) and activated partial thromboplastin time (APTT) measurements, thereby preventing thromboembolic cardiovascular disease (CVD). It further examines the relationship between coagulation parameters, HbA1c, and diabetes duration.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
